Socio-economics is about showing how investing in health can free up resources for other social development purposes. Additional investments in better treatment at an early stage are offset by lower costs to society in the future due to less complications (lower hospitalisation costs, less nursing of irreversible disabilities and higher productivity). The socio-economic consequences are reflected in Novo Nordisk’s current strategy and based on the objective to prevent complications from developing into an irreversible stage where only daily care and nursing homes can be offered.
This page has been assessed by PricewaterhouseCoopers as part of its assessment of Novo Nordisk’s statement that it reports ‘in accordance’ with GRI. Please refer to Audit and assurance for a full description of the nature of assurance offered.
